Literature DB >> 23211057

Standard operating procedures for Peyronie's disease.

Laurence A Levine1, Arthur L Burnett.   

Abstract

INTRODUCTION: Peyronie's disease (PD) refers to a penile deformity that is associated with sexual dysfunction. AIM: To provide recommendations and Standard Operating Procedures (SOPs) based on best evidence for diagnosis and treatment of PD.
METHODS: Medical literature was reviewed and combined with expert opinion of the authors. MAIN OUTCOME MEASURES: Recommendations and SOPs based on grading of evidence-based medical literature.
RESULTS: PD is a fibrotic wound-healing disorder involving the tunica albuginea of the corpora cavernosa. The resulting scar is responsible for a variety of deformities, including curvature, shortening, narrowing with hinge effect, and is frequently associated in the early phase with pain. Patients frequently experience diminished quality erections. All of these conditions can compromise sexual function for the affected male. The etiopathophysiology of PD has yet to be clarified and as a result, effective, reliable, mechanistic directed non-surgical therapy is lacking.
CONCLUSIONS: The management of PD consists of proper diagnosis and treatment, ranging from non-surgical to surgical interventions. The main state of treatment for PD rests at this time on surgical correction that should be based on clear indications, involve surgical consent, and follow a surgical algorithm that includes tunica plication, plaque incision/partial excision and grafting, and penile prosthesis implantation.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 23211057     DOI: 10.1111/j.1743-6109.2012.03003.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  28 in total

1.  Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study.

Authors:  J Twidwell; L Levine
Journal:  Int J Impot Res       Date:  2015-12-24       Impact factor: 2.896

Review 2.  [Conservative therapy of Peyronie's disease - update 2015].

Authors:  G Hatzichristodoulou
Journal:  Urologe A       Date:  2015-05       Impact factor: 0.639

3.  Options for the Medical Treatment of Peyronie's Disease.

Authors:  Laurence A Levine; Sanford J Siegel
Journal:  Rev Urol       Date:  2014

Review 4.  Strategies for penile prosthesis placement in Peyronie's disease and corporal fibrosis.

Authors:  Faysal A Yafi; Premsant Sangkum; Ian Ross McCaslin; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

5.  2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature.

Authors:  Anthony J Bella; Jay C Lee; Ethan D Grober; Serge Carrier; Francois Benard; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2018-02-22       Impact factor: 1.862

Review 6.  A Contemporary Evaluation of Peyronie's Disease During Penile Prosthesis Placement: MOST, MUST, and More.

Authors:  Jonathan Nicholas Warner
Journal:  Curr Urol Rep       Date:  2019-01-30       Impact factor: 3.092

Review 7.  Surgical management of Peyronie's disease.

Authors:  Uwais B Zaid; Amjad Alwaal; Xiaoyu Zhang; Tom F Lue
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

Review 8.  2013-2014 updates in Peyronie's disease management.

Authors:  Benjamin A Sherer; Krishnan Warrior; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

Review 9.  Peyronie's Disease: Intralesional Therapy and Surgical Intervention.

Authors:  Louis A Aliperti; Akanksha Mehta
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

Review 10.  Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections.

Authors:  Mahdi Bazzi; Marcus L Jamil; Ali A Dabaja
Journal:  Curr Urol Rep       Date:  2019-06-14       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.